E-LIB Suche - Ergebnisse für: Sethu Sankaranarayanan

1

A Phase 1 First‐in‐Human Single‐Ascending‐Dose Trial With E..:

France, Nicholas P. ; Rubino, Christopher ; Safir, M. Courtney...
Clinical Pharmacology in Drug Development. 12 (2023) 6 - p. 625-638 , 2023

Link: https://doi.org/10.1002/..

2

Safety and Target Engagement of Complement C1q Inhibitor AN..:

Sun, Yang ; Wirta, David ; Murahashi, Wendy...
Ophthalmology Science. 3 (2023) 2 - p. 100290 , 2023

Link: https://doi.org/10.1016/..

3

Pharmacokinetic and Target Engagement Measures of ANX007, a..:

Grover, Anita ; Sankaranarayanan, Sethu ; Mathur, Vidhu...
Investigative Opthalmology & Visual Science. 64 (2023) 2 - p. 3 , 2023

Link: https://doi.org/10.1167/..

4

Inhibition of C1q Reduces Nerve Damage as Measured by Neuro..:

Tassoni, Alessia ; Mathur, Vidhu ; Vereen, Joseph...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

5

Inhibiting C1q Improves Compound Muscle Action Potential an..:

Andrews-Zwilling, Yaisa ; Mathur, Vidhu ; Kuhn, Logan...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

6

Anti-C1q Therapy ANX005 Inhibits CSF Antibody-Driven Comple..:

Suri, Poojan ; Sankaranarayanan, Sethu ; Cahir-McFarland, Ellen...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

7

Complement factor C1q mediates sleep spindle loss and epile..:

Holden, Stephanie S. ; Grandi, Fiorella C. ; Aboubakr, Oumaima...
Science. 373 (2021) 6560 - p. , 2021

Link: https://doi.org/10.1126/..

8

Inhibition of C1q, Initiator of the Classical Complement Ca..:

Islam, Zhahirul ; Papri, Nowshin ; Jahan, Israt...
Neurology. 94 (2020) 15_supplement - p. , 2020

Link: https://doi.org/10.1212/..

9

The Classical Complement Pathway Mediates Microglia-Depende..:

Vukojicic, Aleksandra ; Delestrée, Nicolas ; Fletcher, Emily V....
Cell Reports. 29 (2019) 10 - p. 3087-3100.e7 , 2019

Link: https://doi.org/10.1016/..

10

Subretinal macrophages produce classical complement activat..:

Jiao, Haihan ; Rutar, Matt ; Fernando, Nilisha...
Molecular Neurodegeneration. 13 (2018) 1 - p. , 2018

Link: https://doi.org/10.1186/..

11

Probing Conformational Dynamics of Tau Protein by Hydrogen/..:

Huang, Richard Y.-C. ; Iacob, Roxana E. ; Sankaranarayanan, Sethu...
Journal of the American Society for Mass Spectrometry. 29 (2017) 1 - p. 174-182 , 2017

Link: https://doi.org/10.1007/..

12

Nonclinical Development of ANX005: A Humanized Anti-C1q Ant..:

Lansita, Janice A. ; Mease, Kirsten M. ; Qiu, Haiyan...
International Journal of Toxicology. 36 (2017) 6 - p. 449-462 , 2017

Link: https://doi.org/10.1177/..

13

C1q-targeted inhibition of the classical complement pathway..:

McGonigal, Rhona ; Cunningham, Madeleine E. ; Yao, Denggao...
Acta Neuropathologica Communications. 4 (2016) 1 - p. , 2016

Link: https://doi.org/10.1186/..

14

Passive Immunization with Phospho-Tau Antibodies Reduces Ta..:

Sankaranarayanan, Sethu ; Barten, Donna M. ; Vana, Laurel...
PLOS ONE. 10 (2015) 5 - p. e0125614 , 2015

Link: https://doi.org/10.1371/..

15

Methyl-substitution of an iminohydantoin spiropiperidine β-..:

Egbertson, Melissa ; McGaughey, Georgia B. ; Pitzenberger, Steven M....
Bioorganic & Medicinal Chemistry Letters. 25 (2015) 21 - p. 4812-4819 , 2015

Link: https://doi.org/10.1016/..